- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
MariMed Reports Strong Q4 2025 Earnings in Massachusetts
Cannabis company highlights performance in key state market
Mar. 12, 2026 at 3:42pm
Got story updates? Submit your updates here. ›
MariMed Inc., a leading cannabis company, reported strong financial results for the fourth quarter of 2025, with a focus on its performance in the Massachusetts market. Andrew Pacheco, General Manager for MariMed in Massachusetts, highlighted the expertise, collaboration, and dedication of the company's employees at its New Bedford cultivation and processing facility, which has contributed to the brand's success in the state. The earnings call also featured comments from CEO Jon Levine, Chief Commercial Officer Ryan Crandall, and Chief Financial Officer Mario Pinho.
Why it matters
MariMed's performance in Massachusetts is significant as the state represents a key market for the company's operations. The strong results demonstrate the company's ability to execute and differentiate itself in a competitive cannabis landscape, which is important for its overall growth and profitability.
The details
During the earnings call, Pacheco praised the commitment and expertise of MariMed's employees in Massachusetts, noting that their dedication to the company's mission has been a key driver of its success in the state. The company's New Bedford facility is responsible for manufacturing its portfolio of brands that are distributed throughout Massachusetts.
- MariMed reported its fiscal year and fourth quarter 2025 earnings on March 12, 2026.
The players
MariMed Inc.
A leading cannabis company that operates in multiple states, including Massachusetts.
Andrew Pacheco
The General Manager for MariMed in Massachusetts, responsible for overseeing the company's operations in the state.
Jon Levine
The Chief Executive Officer of MariMed Inc.
Ryan Crandall
The Chief Commercial Officer of MariMed Inc.
Mario Pinho
The Chief Financial Officer of MariMed Inc.
What they’re saying
“My team at our New Bedford cultivation and processing facility is responsible for the manufacturing of our great brands that is distributed throughout the state. I'm privileged to see firsthand the expertise, collaboration and dedication our employees contribute on a daily basis. They take the company's mission to improve lives every day very seriously.”
— Andrew Pacheco, General Manager, MariMed Massachusetts
What’s next
MariMed plans to continue expanding its operations and brand presence in Massachusetts, leveraging the expertise of its local team to drive further growth in the state.
The takeaway
MariMed's strong performance in Massachusetts highlights the company's ability to execute and differentiate itself in a competitive cannabis market, underscoring the importance of having a dedicated and skilled local team that is committed to the company's mission.


